| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |